Immunome Correlations
IMNM Stock | USD 13.47 1.94 16.83% |
The current 90-days correlation between Immunome and Adagene is 0.24 (i.e., Modest diversification). A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Immunome moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Immunome moves in either direction, the perfectly negatively correlated security will move in the opposite direction.
Immunome Correlation With Market
Weak diversification
The correlation between Immunome and DJI is 0.33 (i.e., Weak diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Immunome and DJI in the same portfolio, assuming nothing else is changed.
Immunome |
Moving together with Immunome Stock
0.75 | HLN | Haleon plc | PairCorr |
0.7 | JNJ | Johnson Johnson Fiscal Year End 28th of January 2025 | PairCorr |
0.72 | LLY | Eli Lilly Sell-off Trend | PairCorr |
0.86 | MRK | Merck Company Fiscal Year End 6th of February 2025 | PairCorr |
0.69 | PFE | Pfizer Inc Aggressive Push | PairCorr |
0.76 | RDY | Dr Reddys Laboratories | PairCorr |
0.8 | TAK | Takeda Pharmaceutical | PairCorr |
0.79 | LTRN | Lantern Pharma | PairCorr |
0.78 | AMGN | Amgen Inc | PairCorr |
0.62 | ANEB | Anebulo Pharmaceuticals | PairCorr |
0.63 | ANRO | Alto Neuroscience, | PairCorr |
0.79 | SIGA | SIGA Technologies | PairCorr |
Moving against Immunome Stock
0.79 | BMY | Bristol Myers Squibb Aggressive Push | PairCorr |
0.74 | ESPR | Esperion Therapeutics | PairCorr |
0.71 | EWTX | Edgewise Therapeutics | PairCorr |
0.61 | GILD | Gilead Sciences | PairCorr |
0.54 | BHC | Bausch Health Companies | PairCorr |
0.5 | VTRS | Viatris | PairCorr |
0.5 | GANX | Gain Therapeutics | PairCorr |
0.47 | EBS | Emergent Biosolutions | PairCorr |
0.4 | BFRIW | Biofrontera Warrants | PairCorr |
0.38 | WAT | Waters | PairCorr |
0.38 | BCTXW | BriaCell Therapeutics | PairCorr |
0.8 | BSX | Boston Scientific Corp | PairCorr |
0.57 | DXCM | DexCom Inc | PairCorr |
0.46 | ABT | Abbott Laboratories Fiscal Year End 22nd of January 2025 | PairCorr |
0.41 | MNMD | Mind Medicine | PairCorr |
0.41 | CPRX | Catalyst Pharmaceuticals | PairCorr |
0.34 | CMND | Clearmind Medicine Common | PairCorr |
0.32 | EW | Edwards Lifesciences Corp | PairCorr |
Related Correlations Analysis
Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Immunome Stock performing well and Immunome Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Immunome's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
---|---|---|---|---|---|---|---|---|---|---|
ANEB | 5.00 | (0.35) | 0.00 | (0.12) | 0.00 | 8.61 | 76.00 | |||
ADAG | 4.44 | (0.25) | 0.00 | (0.78) | 0.00 | 8.13 | 37.93 | |||
ACRV | 2.87 | (0.43) | 0.00 | (0.13) | 0.00 | 7.66 | 22.84 | |||
ANAB | 3.46 | (0.81) | 0.00 | (0.14) | 0.00 | 5.77 | 35.57 | |||
MLYS | 2.68 | (0.10) | 0.02 | 0.07 | 3.38 | 6.27 | 20.98 | |||
MOLN | 4.53 | (0.20) | 0.00 | (0.02) | 0.00 | 9.38 | 52.92 | |||
MNOV | 4.87 | 1.03 | 0.12 | (0.34) | 4.38 | 12.43 | 61.30 | |||
CSBR | 3.36 | (0.19) | 0.00 | (0.05) | 0.00 | 6.56 | 22.49 | |||
CYT | 2.76 | 0.49 | 0.13 | 0.84 | 2.57 | 10.00 | 36.14 | |||
AVTE | 2.45 | 0.45 | 0.18 | 0.57 | 2.04 | 5.58 | 19.11 |
Immunome Corporate Management
Matthew Robinson | Chief Officer | Profile | |
Michael Morin | Chief Scientist | Profile | |
Philip Roberts | Chief Officer | Profile | |
Robert Lapetina | Principal Officer | Profile | |
JD Esq | General Officer | Profile | |
Purnanand Sarma | CEO Pres | Profile | |
Sandra Esq | Gen Officer | Profile |